Loading...
Market
Will clinical trials for a lifespan-extending drug in humans start by the end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Clinical trial registries or official announcements by research institutions
Story
Scientists Develop Drugs, Including mTOR Inhibitor Rapamycin, to Extend Lifespan of Dogs with Implications for Human Longevity
Dec 27, 2024, 05:42 AM
Researchers are exploring new drugs aimed at extending the lifespan of dogs, which may have implications for human longevity. Current studies focus on the development of a pill that could prolong the lives of dogs, with scientists suggesting that similar effects might be applicable to humans. This follows the previous identification of the mTOR inhibitor, Rapamycin, as the only molecule rigorously proven to increase lifespan in healthy mice across various studies. The ongoing research into canine longevity could pave the way for advancements in human health and lifespan extension.
View original story
Similar markets
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Trial discontinued • 25%
Negative results • 25%
Mixed results • 25%
Positive results with MRD-negative CR • 25%
